The emerging era of pharmacogenomics: current successes, future potential, and challenges
出版年份 2014 全文链接
标题
The emerging era of pharmacogenomics: current successes, future potential, and challenges
作者
关键词
-
出版物
CLINICAL GENETICS
Volume 86, Issue 1, Pages 21-28
出版商
Wiley
发表日期
2014-03-29
DOI
10.1111/cge.12392
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Precision genome engineering
- (2014) Dana Carroll CURRENT BIOLOGY
- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- VKORC1andCYP2C9genotypes are predictors of warfarin-related outcomes in children
- (2014) Kaitlyn Shaw et al. PEDIATRIC BLOOD & CANCER
- Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity
- (2013) B C Carleton et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
- (2013) K Pussegoda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Evidence-Based Management of Anticoagulant Therapy
- (2012) Anne Holbrook et al. CHEST
- Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers
- (2012) J Sistonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
- (2012) Lieven Thorrez et al. CURRENT PHARMACEUTICAL DESIGN
- Genetic and Clinical Determinants Influencing Warfarin Dosing in Children With Heart Disease
- (2012) Nguyenvu Nguyen et al. PEDIATRIC CARDIOLOGY
- More Codeine Fatalities After Tonsillectomy in North American Children
- (2012) L. E. Kelly et al. PEDIATRICS
- Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation
- (2012) Frank S Ong et al. PHARMACOGENOMICS
- Pharmacogenetics at 50: Genomic Personalization Comes of Age
- (2012) T. J. Urban et al. Science Translational Medicine
- VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
- (2011) T. T. Biss et al. BLOOD
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population
- (2011) Cecilie Johannessen Landmark et al. EPILEPSY RESEARCH
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomics of cisplatin-induced ototoxicity
- (2011) Debashree Mukherjea et al. PHARMACOGENOMICS
- Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
- (2011) Donna A. Volpe et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium
- (2009) Bruce M. Psaty et al. Circulation-Cardiovascular Genetics
- Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
- (2009) Sindhu Ramchandren et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
- (2009) Vladan Rajić et al. LEUKEMIA & LYMPHOMA
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
- (2009) Catherine Ciszkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
- (2009) Johanna Sistonen et al. Pharmacogenetics and Genomics
- Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers
- (2009) Jörn Lötsch et al. Pharmacogenetics and Genomics
- Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
- (2009) D Caronia et al. PHARMACOGENOMICS JOURNAL
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study
- (2008) P Madadi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antiepileptic drug utilization in children from 1997–2005—a study from the Netherlands
- (2008) N. W. van de Vrie-Hoekstra et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now